Log in
Enquire now
‌

US Patent 9815850 Compounds, compositions and methods

Patent 9815850 was granted and assigned to Denali Therapeutics on November, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Denali Therapeutics
Denali Therapeutics
Current Assignee
Denali Therapeutics
Denali Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9815850
Date of Patent
November 14, 2017
Patent Application Number
15424216
Date Filed
February 3, 2017
Patent Citations Received
0
‌
US Patent 11667643 RIP1K inhibitors
0
‌
US Patent 11834439 Compounds, compositions, and methods
0
‌
US Patent 11919890 RIP1 inhibitory compounds and methods for making and using the same
0
Patent Primary Examiner
‌
Bruck Kifle
Patent abstract

The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9815850 Compounds, compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.